Nicotine Content and Delivery Across Tobacco Products

  • Mirjana V. Djordjevic
  • Kelly  A. Doran
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 192)


Nicotine is the principal alkaloid in both commercial and homemade products (e.g., cigarettes, smokeless tobacco, bidis, waterpipes) followed by nornicotine, anabasine, anatabine, and many other basic substances that contain a cyclic nitrogenous nucleus. Tobacco types, leaf position on the plant, agricultural practices, fertilizer treatment, and degree of ripening are among some prominent factors that determine the levels of alkaloids in tobacco leaf. From a random examination of 152 cultivated varieties of Nicotiana tabacum, a range of alkaloid variation between 0.17 and 4.93% was determined. In fact, every step in tobacco production that affects plant metabolism will influence the level of alkaloid content to a certain degree. Depending on blending recipe, type and amount of additives, and product design, all types of tobacco products contain a very wide range of nicotine concentration. However, the ultimate emission of nicotine to the user, exposure, and psychophar-macological effects depend not only on the content and emission, but also on the relationship between the product and the user.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alpert HR (2008) Manipulation of free nicotine and its dosing to target high risk groups. Paper presented at the cigarette industry's entry into the smokeless tobacco market. Harvard School of Public Health, Boston, MA, July 10, 2008Google Scholar
  2. Ayo-Yusuf OA, Swart TJ, Pickworth WB (2004) Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa. Tob Control 13:186–189PubMedCrossRefGoogle Scholar
  3. Benowitz NL, Henningfield JE (1994) Establishing a nicotine threshold for addiction. The implication of tobacco regulation. New Engl J Med 331:123–125PubMedCrossRefGoogle Scholar
  4. Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsay D, Jacob P III (2007) Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev 16:2479–2485PubMedCrossRefGoogle Scholar
  5. Bhide SV, Nair J, Maru GB, Nair UJ, Kameshwar Rao BV, Chakraborty MK, Brunnemann KD (1987) Tobacco-specific N-nitrosamines (TNSA) in green mature and processed tobacco leaves from India. Beitr Tabakforsch 14:29–32Google Scholar
  6. Bradford JA, Harlan WR, Hanmer HR (1936) Nature of cigarette smoke: technic of experimental smoking. Ind Eng Chem 29:836–839CrossRefGoogle Scholar
  7. Breland AB, Evans SE, Buchhalter AR, Eissenberg T (2002) Acute effects of Advance: a potential reduced exposure product for smokers. Tob Control 11:376–378PubMedCrossRefGoogle Scholar
  8. Borgerding M, Klus H (2005) Analysis of complex mixtures – cigarette smoke. Exp Toxicol Pathol 57:43–73PubMedCrossRefGoogle Scholar
  9. Burns DM, Dybing E, Gray N, Hecht S, Anderson C, Sanner T, O'Connor R, Djordjevic M, Dresler C, Hainaut P, Jarvis M, Opperhuizen A, Straif K (2008) Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control 17:132–141PubMedCrossRefGoogle Scholar
  10. Burton HR, Bush LP, Hamilton JL (1983) Effect of curing on the chemical composition of burley tobacco. Recent Adv Tob Sci 9:91–153Google Scholar
  11. Burton HR, Bush LP, Djordjevic MV (1989a) Influence of temperature and humidity on the accumulation of tobacco-specific nitrosamines in stored burley tobacco. J Agric Food Chem 37:1372–1377CrossRefGoogle Scholar
  12. Burton HR, Childs GH Jr, Andersen RA, Fleming PD (1989b) Changes in chemical composition of burley tobacco during senescence and curing. 3. Tobacco-specific nitrosamines. J Agric Food Chem 37:426–430CrossRefGoogle Scholar
  13. Burton HR, Dye NK, Bush LP (1992) Distribution of tobacco constituents in tobacco leaf tissue. 1. Tobacco-specific nitrosamines, nitrate, nitrite and alkaloids. J Agric Food Chem 40:1050–1055CrossRefGoogle Scholar
  14. Burton HR, Dye NK, Bush LP (1994) Relationship between tobacco-specific nitrosamines and nitrite from different air cured tobacco varieties. J Agric Food Chem 42:2007–2011CrossRefGoogle Scholar
  15. Calafat AM, Polzin GM, Saylor J, Richter P, Ashley DL, Watson CH (2004) Determination of tar, nicotine, and carbon monoxide yields in the mainstream smoke of selected international cigarettes. Tob Control 13:45–51PubMedCrossRefGoogle Scholar
  16. Chamberlain WJ, Chortyk OT (1992) Effects of curing and fertilization on nitrosamine formation in bright and burley tobacco. Chemical composition of nonsmoking tobacco products. Beitr Tabakforsch 15:87–92Google Scholar
  17. Chen J, Higby R, Tian D, Tan D, Johnson MD, Xiao Y, Keller KJ, Feng S, Shields PG (2008) Toxicological analysis of low-nicotine and nicotine free-cigarettes. Toxicology 249:194–203PubMedCrossRefGoogle Scholar
  18. Connolly GN, Alpert HR (2008) Trends in the use of cigarettes and other tobacco products, 2000– 2007. JAMA 299:2629–2630PubMedCrossRefGoogle Scholar
  19. Connolly GN, Alpert HR, Wayne GF, Koh H (2007) Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997–2005. Tob Control 16:e5, 1–8Google Scholar
  20. Counts ME, Morton MJ, Lafoon SW, Cox RH, Lipowicz PJ (2005) Smoke composition and potential relationship for international commercial cigarettes smoked with three machine-smoking conditions. Regul Toxicol Pharmacol 41:185–227PubMedCrossRefGoogle Scholar
  21. DeRoton C, Wiernik A, Wahlberg I, Vidal B (2005) Factors influencing the formation of tobacco-specific nitrosamines in french air-cured tobaccos in trials and at the farm level. Beitr Tabak-forsch 21:305–320Google Scholar
  22. Djordjevic MV, Gay SL, Bush LP, Chaplin JF (1989) Tobacco-specific nitrosamine accumulation and distribution in flue-cured tobacco isolines. J Agric Food Chem 37:752–756CrossRefGoogle Scholar
  23. Djordjevic MV, Sigountos CW, Brunnemann KD Hoffmann D (1990) Tobacco-specific nitro-samine delivery in the mainstream smoke of high- and low-yield cigarettes smoked with varying puff volume. In: CORESTA Symposium Information Bulletin. Hellas, October 7–11 1990, p 209Google Scholar
  24. Djordjevic MV, Sigountos CW, Hoffmann D, Brunnemann KD, Kagan M, Bush LP, Safaev R, Belitsky G, Zaridze D (1991) Assessment of major carcinogens and alkaloids in the tobacco and mainstream smoke of USSR cigarettes. Int J Cancer 47:348–351PubMedCrossRefGoogle Scholar
  25. Djordjevic MV, Hoffmann D, Glynn T, Connolly GN (1995) U.S. commercial brands of moist snuff, 1994. I. Assessment of nicotine, moisture, and pH. Tob Control 4:62–66CrossRefGoogle Scholar
  26. Djordjevic MV, Eixarch L, Hoffmann D (1997) Self-administered and effective dose of cigar smoke constituents. The 51st Tobacco Chemists' Research Conference, Abstr. # 9, Winston-Salem, NC, September 14–17, 1997Google Scholar
  27. Djordjevic MV, Stellman SD, Zang E (2000) Dosages of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst 92:106–111PubMedCrossRefGoogle Scholar
  28. European Parliament (2001) Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products. Off J Eur Commun L 194:26–34Google Scholar
  29. Fant RV, Henningfield JE, Nelson RA, Pickworth WB (1999) Pharmacokinetcs and pharmcody-namics of moist snuff in humans. Tob. Control 8:387–392PubMedCrossRefGoogle Scholar
  30. FTC (2000) “Tar”, nicotine, and carbon monoxide of the smoke of 1294 varieties of domestic cigarettes for the year 1998. Federal Trade Commission Report. FTC, Washington, p. 9Google Scholar
  31. Funk-Brentano C, Raphaël M, Lafontaine M, Arnould J-P, Verstuyft C, Lebot M, Costagliola D, Roussel R (2006) Effects of type of smoking (pipe, cigars or cigarettes) on biological indices of tobacco exposure and toxicity. Lung Cancer 54:11–18CrossRefGoogle Scholar
  32. Greg E, Hill C, Hollywood M, Kearney M, McAdam K, Mclaughlin D, Purkis S, Williams M (2004) The UK smoke constituents testing study. Summary of results and comparison with other studies. Beitr Tabakforsch 21:117–138Google Scholar
  33. Gupta P (2004) Laboratory testing of smokeless tobacco products. final report to the India office of the WHO (allotment No. SE IND TOB 001.RB.02). New DelhiGoogle Scholar
  34. Hatsukami DK, Slade J, Benowitz NL, Giovino GA, Gritz ER, Leischow S, Warner KE (2002) Reducing tobacco harm: research challenges and issues. Nicotine Tob Res (Suppl 2):S89–S101Google Scholar
  35. Hatsukami DK, Giovino GA, Eissenberg T, Clark PI, Lawrence D, Leischow S (2005) Methods to asses potential reduced exposure products. Nicotine Tob Res 7:827–844PubMedCrossRefGoogle Scholar
  36. Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, Hatsukami D (2005) Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev 14:693–698PubMedCrossRefGoogle Scholar
  37. Henningfield JE, Radzius A, Cone EJ (1995) Estimation of available nicotine content in six smokeless tobacco products. Tob Control 4:57–61CrossRefGoogle Scholar
  38. Henningfield JE, Benowitz NL, Slade J, Houston TP, Davis RM, Deitchman SD (1998) Reducing the addictiveness of cigarettes. Tob Control 7:281–293PubMedCrossRefGoogle Scholar
  39. Henningfield JE, Fant RV, Radzius A, Frost S (1999) Nicotine concentrations, smoke pH and whole tobacco aqueous pH of some cigar brands and types popular in the United States. Nicotine Tob Res 1:163–168PubMedCrossRefGoogle Scholar
  40. Henningfield JE, Pankow J, Garrett B (2004) Ammonia and other chemical base tobacco additives and cigarette nicotine delivery: issues and research needs. Nicotine Tob Res 6:199–205PubMedCrossRefGoogle Scholar
  41. Henningfield JE, Stolerman IP, Miczek KA (2006) Nicotine psychopharmacology research: advancing science, public health, and global policy. Psychopharmacology 184:263–265PubMedCrossRefGoogle Scholar
  42. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV (1994) Tobacco-specific N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Env Health 41:1–52CrossRefGoogle Scholar
  43. Hoffmann D, Djordjevic MV, Fan J, Zang E, Glynn T, Connolly GN (1995) Five leading U.S. commercial brands in moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 87:1862–1869PubMedCrossRefGoogle Scholar
  44. Hoffmann D, Hoffmann I, El-Bayoumy K (2001) The less harmful cigarette: a controversial Issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 14:767–790PubMedCrossRefGoogle Scholar
  45. Idris AM, Nair J, Oshima H, Friesen M, Bronet I, Faustman EM, Bartsch H (1991) Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis 12:1115–1118PubMedCrossRefGoogle Scholar
  46. Idris AM, Ibrahim SO, Vasstrand EN, Johannessen AC, Lillehaug JR, Magnusson B, Wallstrom M, Hirsch JM, Nilsen R (1998) The Swedish snus and the Sudanese toombak: are they different? Oral Oncol 34:558–566PubMedCrossRefGoogle Scholar
  47. IARC (1986) Tobacco smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 38. IARC, Lyon, France, p 61Google Scholar
  48. IARC (2004) Tobacco smoke and involuntary smoking. IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 83. IARC, Lyon, FranceGoogle Scholar
  49. IARC (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC monographs on evaluation of carcinogenic risks to humans, vol. 89. IARC, Lyon, FranceGoogle Scholar
  50. Jack A, Fennin N, Bush LP (2007) implications of reducing nornicotine accumulation in burley tobacco. Recent Adv Tob Sci 33:39–92Google Scholar
  51. Jacob P III, Yu L, Shulgin AT, Benowitz NL (1999) Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars and pipes. Am J Pub Health 89:731–736CrossRefGoogle Scholar
  52. Kaiserman MJ, Rickeryt WS (1992) Carcinogens in tobacco smoke: benzo[a]pyrene from Canadian cigarettes and cigarette tobacco. Am L Pub Health 82:1023–1026CrossRefGoogle Scholar
  53. Kozlowski LT, Mehta NY, Sweeney CT, Schwartz SS, Vogler GP, Jarvis MJ, West RJ (1998) Filter ventilation and nicotine content of tobacco of cigarettes from Canada, the United Kingdom, and the United States. Tob Control 7:369–375PubMedCrossRefGoogle Scholar
  54. Laugesen M (2003) Tobacco manufacturers' returns for calendar year 2002. Report to the Ministry of Health, New Zealand. Health New Zealand, 2003Google Scholar
  55. Lee EM, Malson JL, Moolchan ET, Pickworth WB (2004) Quantitative comparison between a nicotine delivery device (Eclipse) and conventional cigarette smoking. Nicotine Tob Res 6: 95–102PubMedCrossRefGoogle Scholar
  56. MacKown CT, Douglas B, Djordjevic MV, Bush LP (1988) Tobacco-specific nitrosamines: formation during processing of midvein and lamina fines. J Agric Food Chem 36:1031–1035CrossRefGoogle Scholar
  57. McNeill A, Bedi R, Islam S, Alkhatib MN, West R (2006) Levels of toxins in oral tobacco products in the UK. Tob Control 15:64–67PubMedCrossRefGoogle Scholar
  58. Malson JL, Sims K, Murty R, Pickworth WB (2001) Comparison of the nicotine content of tobacco used in bidis and conventional cigarettes. Tob Control 10:181–183PubMedCrossRefGoogle Scholar
  59. Malson JL, Lee EM, Moolchan ET, Pickworth WB (2002) Nicotine delivery from smoking bidis and additive-free cigarette. Nicotine Tob Res 4:485–490PubMedCrossRefGoogle Scholar
  60. Malson JL, Lee EM, Murty R, Moolchan ET, Pickworth WB (2003) Clove cigarette smoking: biochemical, physiological, and subjective effects. Pharmacol Biochem Behav 74:739–745PubMedCrossRefGoogle Scholar
  61. Melikian AA, Djordjevic MV, Chen S, Richie JP Jr, Stellman SD (2007a) Impact of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure. Cancer Epi Biomarkers Prev 16:1408–1415CrossRefGoogle Scholar
  62. Melikian AA, Djordjevic MV, Hosey J, Zhang J, Chen S, Zang E, Muscat J, Stellman SD (2007b) Gender differences relative to smoking behavior and emission of toxins from mainstream cigarette smoke. Nicotine Tob Res 9(3):377–387CrossRefGoogle Scholar
  63. Mitacek EJ, Brunnemann KD, Polednak AP, Hoffmann D, Suttajit M (1991) Composition of popular tobacco products in Thailand and its relevance to disease prevention. Prev Med 20:764–773PubMedCrossRefGoogle Scholar
  64. Monzer B, Sepetdjian E, Saliba N, Shihadeh A (2008) Charcoal emissions as a source of CO and carcinogenic PAH in mainstream narghile WP smoke. Food Chem Toxicol 46:2992–2995Google Scholar
  65. National Cancer Institute (2001) Risk associated with smoking cigarettes with low machine-measured yields of tar and nicotine. In: Smoking and tobacco control monograph no.13. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Washington, DCGoogle Scholar
  66. Neergaard J, Singh P, Job J, Montgomery S (2007) Waterpipe smoking and nicotine exposure: E review of the current evidence. Nicotine Tob Res 9:987–994PubMedCrossRefGoogle Scholar
  67. O'Connor RJ, Hurley PJ (2008) Existing technologies to reduce specific toxicant emissions in cigarette smoke. Tob Control 17:i39–i48 doi:1136/tc.2007.023689PubMedCrossRefGoogle Scholar
  68. Pakhale SS, Maru GB (1998) Distribution of major and minor alkaloids in tobacco, mainstream, and sidestream smoke of popular Indian smoking products. Food Chem Toxicol 36:1131–1138PubMedCrossRefGoogle Scholar
  69. Peele DM, Danehower DA, Goins GD (1995) Chemical and biochemical changes during flue curing. Recent Adv Tob Sci 21:81–133Google Scholar
  70. Pillsbury HC (1996) Review of the federal trade commission method for determining cigarette tar and nicotine yield. In: The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of U.S. cigarettes. Report of the NCI Expert Committee. Smoking and tobacco control monograph no.7. U.S. Department of Health and Human Services. National Institutes of Health, National Cancer Institute, Bethesda, MD, NIH Publication no. 96–4028Google Scholar
  71. Rees VW, Wayne JF, Thomas BF, Connolly GN (2007) Physical design analysis and mainstream smoke constituent yields of new potential reduced exposure product, Marlboro UltraSmooth. Nicotine Tob Res 9:1197–1206PubMedCrossRefGoogle Scholar
  72. SCENIHR (2008) Health effects of smokeless tobacco. Opinion adopted by Scientific Committee on Emerging and Newly Identified Health Risks at the 22nd plenary on February 6, 2008. risk/committees/04 scenihr/scenihr cons 06 en.htm
  73. Siminszky B, Gavilano LB, Chakrabarti M (2007) Evolution of nicotine N-demethylaze genes and their use in reducing nornicotine levels in tobacco. Recent Adv Tob Sci 33:27–38Google Scholar
  74. Sisson VA, Severson RF (1990) Alkaloid composition of the Nicotiana species. Beitr Takforsch 14:327–340Google Scholar
  75. Shihadeh A (2003) Investigation of mainstream aerosol of the argileh waterpipe. Food Chem Toxicol 41:143–152PubMedCrossRefGoogle Scholar
  76. Shihadeh A, Saleh R (2005) Polycyclic aromatic hydrocarbons, carbon monoxide, “tar”, and nicotine in the mainstream smoke aerosol of the narghile water pipe. Food Chem. Toxicol 43: 655–661PubMedCrossRefGoogle Scholar
  77. Stanfill SB, Brown CR, Yan X, Watson CH, Ashley DL (2006) Quantification of flavor-related compounds in the unburned contents of bidi and clove cigarettes. J Agric Food Chem 54: 8580–8588PubMedCrossRefGoogle Scholar
  78. Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA (2007) New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend 86:294–300PubMedCrossRefGoogle Scholar
  79. Stratton K, Shetty P, Wallace R, Bondurant S (2001) Clearing the smoke. Assessing the science base for tobacco harm reduction. National Academy Press, Washington DCGoogle Scholar
  80. Stepanov I, Carmella SG, Hecht SS, Duca G (2002) Analysis of tobacco-specific nitrosamines in Moldovan cigarette tobacco. J Agric Food Chem 50:2793–2797PubMedCrossRefGoogle Scholar
  81. Stepanov I, Jensen J, Hatsukami D, Hecht SS (2008) New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 10(12):1773–1782PubMedCrossRefGoogle Scholar
  82. Tso TC (1990) Organic metabolism- alkaloids. In: Tso TC (ed) Production, physiology and biochemistry of tobacco plant. IDEALS, Beltsville, MD, pp 427–486Google Scholar
  83. USDHHS (2004) The health consequences of smoking: a report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GAGoogle Scholar
  84. Walton LR, Burton HR Swetnam LD (1995) Effect of mechanization on the physical appearance and chemical composition of burley tobacco. Recent Adv Tob Sci 21:3–38Google Scholar
  85. Wangan KR, Biørn E (2001) Prevalence and substitution effects in tobacco consumption: a discrete choice analysis of panel data. No. 312. Statistics Norway, Research Department, NorwayGoogle Scholar
  86. Watson CH, Polzin GM, Calafat AM, Ashley DL (2003) Determination of tar, nicotine, and carbonmonoxide yields in the smoke of bidi cigarettes. Nicotine Tob Res 5:747–753PubMedCrossRefGoogle Scholar
  87. Young D, Borland R, Hammond D, Cummings KM, Devlin E, Yong H-H, O'Connor RJ (2006) Prevalence and attributes of roll-your-own smokers in the International Tobacco Control (ITC) four country survey. Tob Control 15(Suppl III):iii76–iii82PubMedCrossRefGoogle Scholar
  88. Young D, Yong H-H, Borland R, Ross H, Sirirassamee B, Kin F, Hammond D, O'Connor RJ, Fong GT (2008) Prevalence and correlates of roll-your-own smoking in Thailand and Malaysia: findings of the ITC-South East Asia survey. Nicotine Tob Res 10:907–915PubMedCrossRefGoogle Scholar
  89. Yu J, Taylor LT, Aref S, Bodnar JA, Borgerding MF (2006) Influence of puffing parameters and filter vent blocking condition on nicotine fate in a burning cigarette. Part 1. Full flavor cigarette. Beitr Takforsch 144:185–195Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Mirjana V. Djordjevic
    • 1
  • Kelly  A. Doran
    • 2
  1. 1.Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population SciencesNational Cancer InstituteBethesdaUSA
  2. 2.DB Consulting Group Inc, Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population SciencesNational Cancer InstituteBethesdaUSA

Personalised recommendations